Evidence map›Paper›PMID 37708091›Full record

ArticleAging2023

Correction for: FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination.

Songbai Liu, Peng Liu, Changhao Zhu, Rui Yang, Zhiwei He, Yongning Li, Ying Li, Xiaobin Fei, Junyi Hou, Xing Wang and 1 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Songbai LiuGuizhou Medical University, Guiyan, Guizhou 550000, China.
Peng LiuGuizhou Medical University, Guiyan, Guizhou 550000, China.
Changhao ZhuDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyan, Guizhou 550000, China.
Rui YangDepartment of Hepatobiliary Surgery, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhe, Guangdong 518055, China.
Zhiwei HeDepartment of Hepatobiliary Surgery, Shenzhen Key Laboratory, Shenzhen University General Hospital, Shenzhe, Guangdong 518055, China.
Yongning LiDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Hospital of Guizhou Medical University, Guiyan, Guizhou 550000, China.
Ying LiDepartment of Hepatic-Biliary-Pancreatic Surgery, The Affiliated Cancer Hospital of Guizhou Medical University, Guiyan, Guizhou 550000, China.
Xiaobin FeiGuizhou Medical University, Guiyan, Guizhou 550000, China.
Junyi HouGuizhou Medical University, Guiyan, Guizhou 550000, China.
Xing WangGuizhou Medical University, Guiyan, Guizhou 550000, China.
Yaozhen PanGuizhou Medical University, Guiyan, Guizhou 550000, China.
Guiyang Medical University · CNAffiliated Hospital of Guizhou Medical University · CNShenzhen University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

FBXO28pancreatic cancerproliferationSMARCC2ubiquitination

Identifiers

PMID37708091
PMCPMC10522369
OpenAlexW4386738244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.